Plant-derived (poly)phenolic compounds have been undoubtedly shown to promote endocrine homeostasis through the improvement of diverse metabolic outcomes. Amongst diverse potential mechanisms, the prebiotic modulatory effects exerted by these compounds on the gut microbiota have supported their nutraceutical application in both experimental and clinical approaches. However, the comprehension of the microbiota modulatory patterns observed upon (poly)phenol-based dietary interventions is still in its infancy, which makes the standardization of the metabolic outcomes in response to a given (poly)phenol a herculean task. Thus, this narrative review sought to gather up-to-date information on the relationship among (poly)phenols intake, their modulatory effect on the gut microbiota diversity, and consequent metabolic outcomes as a supportive tool for the future design of experimental approaches and even clinical trials.
AuthorsPerla Lopes de Freitas Joã o Paulo Nascimento Miranda Lucas Martins Franç a Antonio Marcus de Andrade Paes
Published Date26 august 2022
- Inhibition of ALDH2 by quercetin glucuronide suggests a new hypothesis to explain red wine headaches
- Role of dietary polyphenols in non-communicable chronic disease prevention, and interactions in food systems: An overview
- Polyphenol-Rich Beverages and Mental Health Outcomes
- Effect of Resveratrol Content in Red Wine on Circulating Sex Hormone-Binding Globulin: Lessons from a Pilot Clinical Trial
- Updated Information of the Effects of (Poly)phenols against Type-2 Diabetes Mellitus in Humans: Reinforcing the Recommendations for Future Research